MagVenture launches portable TMS system for clinical mobility

By AI, Created 5:25 PM UTC, May 18, 2026, /AGP/ – MagVenture on May 13 unveiled MagVenture Go, a portable transcranial magnetic stimulation system built to make treatment easier to move, schedule and deploy across clinics. The system is aimed at practices that want more flexibility without changing established TMS workflows.

Why it matters: - MagVenture Go is designed to make transcranial magnetic stimulation easier to fit into everyday clinic operations. - The portable format could help multi-site practices, lower-volume clinics and offices that need to move equipment between locations. - MagVenture also positions the system as an entry point for practices starting TMS programs.

What happened: - MagVenture announced the MagVenture Go Portable TMS system on May 13, 2026. - The launch adds a compact, mobile transcranial magnetic stimulation option to MagVenture’s product line. - The company plans to show the new system at the APA meeting in San Francisco from May 16-20 and at the CTMSS annual meeting in Boston from June 4-6.

The details: - MagVenture Go is a complete TMS and peripheral pain therapy system built on the MagPro R20 platform. - The system comes in a durable rolling case for transport and setup. - MagVenture Go supports repetitive TMS and intermittent theta burst stimulation protocols. - The system is cleared to support nine coils for psychiatric and peripheral pain therapy applications, including the MMC-140-II, MCF-140, MCF-B65, MCF-B70, C-B70, RT-120-II, MMC-90 and MCF-125 coils. - The system is compatible with non-cooled and static-cooled coils. - MagVenture says the product can be offered with a low monthly cost structure for practices that want a more accessible way to adopt TMS. - The company says the system is built to maintain clinical standards associated with MagVenture systems.

Between the lines: - The launch reflects a broader push in medical devices toward portability and workflow efficiency, especially where capital equipment has to serve multiple rooms or sites. - MagVenture is framing the product as both a clinical tool and an operational fix, which suggests the sales pitch is aimed as much at practice managers as at clinicians. - The portable design may reduce one of the practical barriers to broader TMS adoption: where and how the equipment can be deployed.

What’s next: - MagVenture Go will reach clinicians and buyers first through the two spring conference appearances. - The company appears to be targeting practices that want to add or expand TMS without committing to a fixed installation. - Broader adoption will likely depend on how easily clinics can integrate the system into existing scheduling, staffing and reimbursement workflows.

The bottom line: - MagVenture is betting that portability will be the next differentiator in TMS, not just treatment capability.